Received: 15 April 2020
Accepted: 3 September 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: The study will be performed in agreement with the dictates of the Helsinki Declaration and the rules of Good Clinical Practice (E6: Good Clinical Practice: Consolidated Guideline (CPMP/ICH/135/95)). The permission of the Ethical Committee is wanted and the request to conduct a prospective study is sent to the Institutional Authority (protocol number approval: 13646). Before starting the study, every participant will be accurately informed about the management of the resected specimen and will be given the informative letter for them and for their general practitioner, the forms of the informed consent, and the one for the treatment of their clinical data for research purposes. All participants will be registered after signing the informed consent. The informed consent to participate to the “EXLIPSE” research study does not apply to group B since the authorisation to organ donation in our region implies also the consent to investigate the explanted organs for scientific purposes (Tuscany Transplant Organization, OTT/SR/001.HB).
: Included in consent to participate to the study